Posts With Tag cyclodextrins

Explore CTD Holdings, Inc.'s financial performance for Q1 2010, highlighting sales growth, cash flow issues, and strategic developments amid risks.

Explore CTD Holdings, Inc.'s 2023 financial report highlighting revenue growth, profitability, and risks. Key insights for investors on customer concentration and future strategies.

Explore CTD Holdings, Inc.'s 10-K filing for FY 2010, revealing revenue growth, net loss, and strategic shifts. Key insights on risks and recommendations for investors.

Explore CTD Holdings, Inc.'s Q3 2012 financial performance with a focus on assets, liabilities, and declining sales. Investment recommendation: Hold. Monitor for future growth potential.

Explore CTD Holdings, Inc.'s Q2 2013 financial performance, highlighting a 142% revenue rise, improved profitability, and a strong buy recommendation for investors.

Explore CTD Holdings' 2011 financial performance, highlighting a net loss, revenue challenges, and growth strategies. Key insights into cyclodextrin market dynamics and operational risks.

Explore CTD Holdings, Inc.'s 2009 10-K filing, highlighting revenue growth, strategic risks, and a hold recommendation for investors amidst regulatory challenges.